Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-050071
Filing Date
2021-08-05
Accepted
2021-08-05 21:18:59
Documents
2
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4270
2 EX-24 DOCUMENT attachment1.htm EX-24 3775
  Complete submission text file 0001209191-21-050071.txt   9450
Mailing Address C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Henderson Jane (Reporting) CIK: 0001422304 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40703 | Film No.: 211150333

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)